 - Subjects should not take any concomitant anti-asthma except short-acting inhaled β2-agonists SABAs or anti-allergy medication for at least 6 weeks prior to the screening visit and throughout the study period. Antihistamines will be permitted up to 7 days prior to the first screening visit. 